Clinical trial
The Impact of Comorbidity as a Risk Factor of Acute Kidney Injury (AKI) in Patients With Stable Coronary Artery Disease (CAD)
NCT04014153 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Comorbidity as a Risk Factor of Acute Kidney Injury (AKI) in Patients With Stable Coronary Artery Disease (CAD)
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 16, 2012
- Completion date
- December 12, 2018
- Enrollment
- 1,023 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, contrast-induced nephropathy, stable angina